Dante Pazzanese

1 similar search for Dante Pazzanese

Dante Pazzanese de Cardiologia

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

25 documents for Dante Pazzanese

- Low-Salt Diet May Lower Blood Pressure
The study team concludes that these findings clearly demonstrate the harmful effects of a high-salt diet in people with stubborn hypertension, as well as the benefits of a low-salt diet. "The blood pressure reduction achieved with low-salt diet was higher than some antihypertensive drugs," said lead researcher Dr. Eduardo Pimenta, now at the Department of Hypertension and Nephrology at the Dante Pazzanese Institute of Cardiology in Sao Paulo, Brazil. "We were expecting blood pressure reduction with low-salt diet but the reduction was larger than we expected. Dr. Gregg C. Fonarow, professor of cardiology at the University of California, Los Angeles, called the study "small, but interesting" and agreed that salt reduction could have a substantial impact on lowering blood pressure for pat...
- Culvert Chronicles, The
- August 28, 2009
- Elixir Medical Corporation Announces Excellent Six-Month Safety and Efficacy Results from the EXCELLA BD Randomized Clinical Trial for DESyne BD[TM] Novolimus Eluting Coronary Stent with Biodegradable Polymer.
- Business Wire
- November 09, 2011
- InSeal Medical Announces Patients Successfully Treated with Novel Intravascular Large Bore Puncture Closure Device.
... of Coronary Interventions at the Institute Dante Pazzanese of Cardiology in Sao Paulo, Brazil, wher...
- Business Wire
- November 09, 2011

- Elixir Medical Receives CE Mark for DESyne[TM] Novolimus Eluting Coronary Stent System.
... Abizaid, M.D., Ph.D., from the Instituto Dante Pazzanese de Cardiologia in Sao Paulo, Brazil, co-...
- Business Wire
- May 23, 2011
- Elixir Medical Corporation Announces Successful Completion of First-In-Man Study Enrollment for Fully Bioresorbable Drug Eluting Coronary Scaffold System.
... Abizaid, M.D., Ph.D., of the Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil. * Mar...
- Business Wire
- November 02, 2011
- Svelte[TM] Medical Systems, Inc. Completes 6 month Follow-up With Its "All In One" Stenting System.
... of Coronary Interventions at Institute Dante Pazzanese de Cardiologia, Sao Paulo, Brazil noted,...
- Business Wire
- March 21, 2011
- NEVO[TM] Sirolimus-eluting Coronary Stent Continues to Demonstrate Excellent Safety and Efficacy Outcomes in New Twelve-Month Data.
- Business Wire
- May 25, 2010
- First Patients Enrolled in MIV Therapeutics VESTASYNC II Study.
... Chief of Coronary Intervention of Institute Dante Pazzanese of Cardiology in Sao Paulo, Brazil, is a...
- Business Wire
- May 21, 2008
- Elixir Medical Corporation Initiates Enrollment in the EXCELLA BD Randomized Clinical Trial of the Elixir Novolimus Eluting Coronary Stent System with Bioabsorbable Polymer.
- Business Wire
- September 17, 2010
- MIV Therapeutics Announces Start of Clinical Trial Marking First Ever Human Implantation of a Hydroxyapatite Coated Stent.
...Alexandre Abizaid of Institute Dante Pazzanese of Cardiology in Sao Paulo, Brazil. Dr. ...
- Business Wire
- May 31, 2007